Clinical Trials Directory

Trials / Completed

CompletedNCT02596022

The Effect of Glutamatergic Modulation on Cocaine Self-administration

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
18 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Repeated drug consumption may progress to problematic use by triggering neuroplastic adaptations that attenuate sensitivity to natural rewards while increasing reactivity to craving and drug cues. Converging evidence suggests that glutamate modulation may work to correct these adaptations and rapidly restore motivation for delayed non-drug rewards relative to immediate drug use. Using an established laboratory model aimed at evaluating behavioral shifts in the salience of cocaine now vs. money later, the investigators will test the effect of CI-581a on cocaine self-administration as compared to the active control.

Conditions

Interventions

TypeNameDescription
DRUGCI-581aa 50 minute infusion 24 hours prior to cocaine self-administration session
DRUGCI-581ba 50 minute infusion 24 hours prior to cocaine self-administration session

Timeline

Start date
2013-06-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2015-11-04
Last updated
2018-06-15
Results posted
2017-10-17

Source: ClinicalTrials.gov record NCT02596022. Inclusion in this directory is not an endorsement.

The Effect of Glutamatergic Modulation on Cocaine Self-administration (NCT02596022) · Clinical Trials Directory